Evidence map›Paper›PMID 40853111›Full record

ArticlemBio2025

Investigating genetic, antigenic, and structural diversity in the

Odile B Harrison, Margaret Bash, Fidel Ramirez-Bencomo, Angela Thistlethwaite, Rebekah Jones, Lenka Stejskal, Eduard Sanders, Ian M Feavers, Ann Jerse, Jeremy P Derrick and 2 more

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Odile B HarrisonNuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-1623-0295
Margaret BashU.S. Food and Drug Administration, Washington, DC, USA.
Fidel Ramirez-BencomoSchool of Biological Sciences, Lydia Beck Institute of Immunology and Inflammation, The University of Manchester, Manchester, United Kingdom.
Angela ThistlethwaiteSchool of Biological Sciences, Lydia Beck Institute of Immunology and Inflammation, The University of Manchester, Manchester, United Kingdom.
Rebekah JonesSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Lenka StejskalSchool of Biological Sciences, Lydia Beck Institute of Immunology and Inflammation, The University of Manchester, Manchester, United Kingdom.
Eduard SandersThe Aurum Institute, Johannesburg, South Africa.
Ian M FeaversDepartment of Biology, University of Oxford, Oxford, United Kingdom.
Ann JerseDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
Jeremy P DerrickSchool of Biological Sciences, Lydia Beck Institute of Immunology and Inflammation, The University of Manchester, Manchester, United Kingdom.
Christoph M TangSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Martin C J MaidenDepartment of Biology, University of Oxford, Oxford, United Kingdom.

Funding

Wellcome TrustWellcome Trust 214374/A/18/Z
6 · The paper itself

Abstract

Vaccines targeting IMPORTANCE: In the context of rising global gonorrhea cases, the development of vaccines becomes a priority; however,

Indexed as

Antigenic VariationAntigens, BacterialBacterial VaccinesGenetic VariationNeisseria gonorrhoeaePorinsBacterial Outer Membrane ProteinsGenome, BacterialGonorrheaHumansPhylogenyWhole Genome SequencingAntigens, BacterialBacterial Outer Membrane ProteinsBacterial Vaccinesporin protein, NeisseriaPorinsgenomicsgonorrheamachine-learningvaccine

Identifiers

PMID40853111
PMCPMC12509796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.